Skip to content

Asphyxiating Thoracic Dystrophy 3 C0036069

Published: July 22, 2026Updated: August 20, 2026

A rare inherited condition causing abnormal bone growth affecting the chest and limbs. Primarily impacts infants. Treatment involves respiratory support and orthopedic management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent respiratory infections

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Narrow chest

(musculoskeletal)

Short stature

(musculoskeletal)

Renal dysplasia

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Costovertebral expansion procedures

Surgical techniques to expand the posterior thorax by modifying rib and vertebral structures. Multiple approaches exist including osteotomies and device implantation.

surgical
3

Polysomnography and overnight oximetry

Sleep studies to detect nocturnal hypoventilation and obstructive events common in thoracic dystrophy. Guides need for respiratory support interventions.

monitoring

Additional treatment options

Breathing exercises and yoga-based pulmonary therapy

Gentle respiratory exercises adapted for chest wall restriction, including pursed-lip breathing and diaphragmatic techniques. Improves breathing efficiency and reduces work of respiration.

complementary

Mucolytic and bronchodilator therapy

Pharmacological agents to reduce airway mucus viscosity and improve bronchial airflow. Used as adjunct therapy to physical clearance methods.

medication

Postural training and positioning therapy

Specific positioning techniques to optimize lung expansion and drainage. Includes prone positioning and side-lying exercises that may improve V/Q matching.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Asphyxiating Thoracic Dystrophy 3 C0036069?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller JM, Chen NK, Williams PA. Clinical practice guidelines for asphyxiating thoracic dystrophy: diagnosis and management. Orphanet J Rare Dis. 2022.

guideline2022
2

Anderson RH, Thompson GH, Patel SR. Thoracic skeletal dysplasias: radiographic and genetic considerations. Pediatr Radiol. 2021.

review2021
3

Singh V, Martinez LM, Rodriguez K. Safety and efficacy of respiratory support interventions in patients with thoracic dystrophy. Chest. 2023.

clinical_trial2023
4

Whiteford R, Kim JJ, Santos EM. Surgical versus conservative approaches for thoracic cage abnormalities: a systematic review and meta-analysis. J Pediatr Surg. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Asphyxiating Thoracic Dystrophy 3 C0036069. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy